Revolutionary Migraine Treatment Emerges: Double the Relief, Zero Cost!

A groundbreaking new study from NYU Langone Health has revealed that a simple and free smartphone application guiding patients through progressive muscle relaxation (PMR) therapy is twice as effective as traditional remedies in reducing migraine headache pain and disability. The 'RELAXaHEAD' app, freely available in both Apple and Google app stores, offers a non-pharmacological approach to managing this debilitating neurological condition, which affects approximately 39 million Americans.
Progressive Muscle Relaxation (PMR) is a technique originally developed by Dr. Edmund Jacobson in the early 1920s and detailed in his 1938 publication, 'Progressive Relaxation.' It involves systematically tensing each muscle group in the body for several seconds, followed by a slow release of tension, while focusing on the sensation of relaxation. While initially used to treat anxiety symptoms, PMR has more recently been found effective for a range of conditions including tension headaches, temporomandibular joint disorder (TMJ), neck pain, insomnia, bipolar disorder, backaches, and high blood pressure, in addition to migraines.
The clinical trial involved 69 participants, aged 18 to 65, who sought care for migraines at NYU Langone Health's emergency departments between 2019 and 2021. Participants were randomly assigned to one of two groups: an intervention group that used the RELAXaHEAD app with PMR audio files for several minutes daily, or a control group that used the app solely as a headache diary. All participants were required to use the app for daily symptom reporting, tracking headache days, sleep, medications, adverse effects, menstrual cycles, and optional notes.
The PMR group had access to various audio files, including a five-minute deep-breathing session, a six-minute brief PMR session, a longer 12.5-minute PMR session, and an 8.5-minute muscle scan session. These participants were asked to complete app-based PMR for 10 to 15 minutes daily for a minimum of 60 days, aiming for daily use throughout the 90-day treatment period. The study utilized the Migraine Disability Assessment Score (MIDAS), a questionnaire assessing migraine-related disability over three months, with scores ranging from 0 to 35, where higher scores indicate greater disability.
Remarkably, the study found that patients who practiced PMR daily for 60 days using the app experienced nearly a 50 percent reduction in their migraine headache pain. Furthermore, the percentage of patients who achieved at least a five-point improvement in their MIDAS scores was 82 percent in the PMR group, significantly higher than the 46 percent in the control group. Researchers also observed a dose-response relationship, indicating that more frequent PMR use led to better outcomes. These significant findings were published in JAMA Network Open.
Dr. Mia Minen, lead study author and associate professor at NYU Grossman School of Medicine, emphasized the potential of smartphone-based interventions to empower patients in self-managing their migraines and reducing disability without relying on medication. She expressed hope that this approach would also decrease the rate at which patients return to emergency departments for migraine relief. Looking ahead, the NYU Langone Health team is conducting a larger-scale clinical study to evaluate the app's effectiveness for migraine patients in primary care settings, where most individuals initially seek treatment.
Migraines are characterized by severe throbbing pain or a pulsing sensation, typically on one side of the head. Beyond a typical headache, migraines can worsen with movement, light, and sound, and often accompanied by nausea, vomiting, numbness in limbs, and vision changes. The pain can spread to the eyes, face, sinuses, jaw, and neck, severely disrupting daily life. Warning signs, or 'auras,' may include zigzag lines, flashing lights, numbness, tingling, dizziness, or difficulty speaking, though migraines can also occur without warning. Attacks can last from hours to several days. While conventional treatments like over-the-counter and prescription pain relievers, along with lifestyle adjustments, can offer relief, they often come with undesirable side effects and considerable costs. Although the exact cause of migraines remains unknown, theories suggest specific nerves in blood vessels sending pain signals to the brain, releasing inflammatory substances, and the role of stress, anxiety, and emotional triggers in contributing to migraine onset.
You may also like...
Your Cover Letter Might Be The One Costing You the Job
Your cover letter could be the reason you are not getting callbacks. This is what recruiters are actually looking for, h...
The Untold Stories Behind Everyday Objects: How History Hides in Plain Sight
Everyday objects tell extraordinary stories—from jeans that sparked rebellion, to pencils that shaped ideas, to coffee c...
Top 10 Oil-Producing States in Nigeria by Daily Crude Output
Here are the top 10 oil-producing states in Nigeria ranked by daily crude output, according to Intelpoint data, and see ...
Djibouti Bases and the Iran-US War: Why Africa Could Become a Battlefield Next
Djibouti’s strategic military bases and location at the Bab-el-Mandeb Strait are pulling Africa into the orbit of the Ir...
Heat's Playoff Hopes Dented: Miami Falls to Raptors, Faces Play-In Gauntlet for Fourth Time

The Miami Heat are heading to the NBA play-in tournament for the fourth consecutive year, despite their expressed desire...
Wemby Scare: Spurs Star Victor Wembanyama Dodges Major Injury, Status Doubtful for Blazers Clash

San Antonio Spurs star Victor Wembanyama is doubtful for Wednesday's game due to a rib contusion, but is expected to pla...
Shocking Revelation: 'Euphoria' Creator Sam Levinson Drops Bombshells on Angus Cloud Loss and Season 4's Fate

"Euphoria" Season 3 faced immense challenges, including the deaths of Angus Cloud and Eric Dane's ALS diagnosis, with cr...
Exclusive: Norwegian Horror Sensation ‘You’ve Been Chosen’ Secures Global Distribution Deal at Cannes

Blue Finch Films is set to represent Viljar Bøe's psychological horror film "You've Been Chosen" as its worldwide sales ...


